ARVEKAP

This brand name is authorized in Cyprus, Malta

Active ingredients

The drug ARVEKAP contains one active pharmaceutical ingredient (API):

1 Triptorelin UNII 9081Y98W2V - TRIPTORELIN
Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins. Read about Triptorelin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02AE04	Triptorelin	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MT	Medicines Authority	Identifier(s): AA770/16601

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.